Oct 1, 2015
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a collaboration with Mitsubishi Tanabe Pharma Corporation (TSE: 4508) (MTPC) providing MTPC with exclusive development and commercial rights to fasinumab (REGN475), Regeneron’s NGF antibody in late-stage...
Sep 2, 2015
The course will take place at the waterfront offices of Gunderson, Dettmer in downtown Boston and includes all the important steps of deal preparation and execution including commercial assessment, valuation, outreach and negotiations. We hope you can join us. Event...
Aug 24, 2015
The panel is Part III of MassBio’s Forum Series: The New Biopharma BD Landscape—All You Need to Know to Survive & Thrive. Hear Jay Mohr moderate on Tuesday, September 22nd at 8:00 a.m. Click here for the link.
Jul 23, 2015
Questions that Cause Biotech CEOs to Lose Sleep: Should I divert funds to the new and promising program or stay focused? Does my team have the skills to take us to the next level? Is our board the right board for the company we want to be? How can I get the best...
Apr 21, 2015
We are pleased to update you about Locust Walk Partners’ leadership role in the upcoming Allicense 2015 Conference. This is the premier event for deal-making, licensing and business development professionals. It will be held on May 5-6, 2015 at the Park...
Mar 3, 2015
Locust Walk Managing Director, Chris Ehrlich, featured on Thomson Reuters webinar “The Five Most Innovative M & A and Licensing Deals” – 2014.” On demand listening available here.
